ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $646,650 | -15.2% | 27,000 | -33.3% | 0.02% | -25.8% |
| Q1 2023 | $762,210 | -33.2% | 40,500 | -49.9% | 0.03% | -44.6% |
| Q2 2022 | $1,141,000 | +214.3% | 80,900 | +439.3% | 0.06% | +229.4% |
| Q1 2022 | $363,000 | +62.8% | 15,000 | +73.5% | 0.02% | +142.9% |
| Q1 2021 | $223,000 | -46.9% | 8,647 | -44.7% | 0.01% | -70.8% |
| Q1 2019 | $420,000 | -90.6% | 15,644 | -94.7% | 0.02% | -89.6% |
| Q2 2018 | $4,471,000 | – | 292,769 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |